retatrutide vs semaglutide side effects – Comparison & Benefits Retatrutide vs. semaglutide: A head-to-head

The Phase 2 trial published in the New England Journal of Medicine in 2023 reported up to 24% average weight loss at 48 weeks at the highest dose the largest number ever recorded for an obesity drug

Until retatrutide receives regulatory approval, NICE guidance on weight management directs clinicians towards licensed options within established care pathways

Retatrutide may ease knee pain too Eli Lillys latest retatrutide phase 3 clinical trial results are from a study called TRIUMPH-4, which was done on people with a BMI of 35 or higher (thats at least 204 pounds for a 54 woman)

Your dose may need to go up as your treatment progressesyour price won't

They are not interchangeable without provider guidance

Dose escalation must follow FDA-approved schedules and be guided by your glycemic control, tolerability, and individual clinical factors to ensure safety and effectiveness